Banisilon, Johnmark J.

HRN: 25-17-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2024
CEFTRIAXONE 1G (VIAL)
06/01/2024
06/08/2024
IV
2g
Q24
Lacerated Wound Inguinal Area
Waiting Final Action 
06/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2024
06/08/2024
IV
600mg
Q8
Lacerated Wound Inguinal Area
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: